News

But mask-wearing still vital to slowing spread of disease, agency says.

This week's edition of the Mainstream Patients features stories about rosemary oil for hair, Ava Max dealing with Covid-19 hair loss, and more.

Click to see a preview of what to expect this week.

ICYMI, some of this week’s featured content includes an exclusive interview about lasers and acne, and articles on 2021's top 20 stories, the declining preference for telehealth, and more.

Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of December

Dermatology Times® broke the news that the carcinogen benzene was found in multiple sunscreens, but that wasn’t the only major headline of the year. We revisit the 20 stories of 2021 that made the greatest impact.

Two possible explanations for declining contentment with live video calls as a form of care delivery.

A recent study investigates the probability of BDD in cosmetic dermatology with the help of a new screening tool.

This week's edition of the Mainstream Patients features stories about the best hair removal methods, pH levels in the skin, and more.

Click to see a preview of what to expect this week.

Don't Forget to take this week's poll.

ICYMI, some of this week’s featured content includes an exclusive interview about the occupational dermatoses, and articles on 2021's breakthroughs and disappointments, the risk of psoriasis related to BMI and more.

The past year gave dermatologists ample cause for both celebration and frustration as they looked forward to new drugs, devices, and technology to optimize patient care. Here, Dermatology Times® editorial advisory board members weigh in on the good, bad, and still-TBD changes that shaped the specialty during 2021.

This week's edition of the Mainstream Patients features stories about how to identify DMDM for hair loss, PRF Fillers, and more.

Click to see a preview of what to expect this week.

Click here to answer this week's poll.

ICYMI, some of this week’s featured content includes an exclusive interview about the iPLEDGE program issues, and articles on FDA approval of upadacitinib for psoriatic arthritis, ruxolitinib cream receiving Priority Review from the FDA for vitiligo, and more.

John Barbieri, MD, MBA, FAAD, speaking in his capacity as a member of the AADA iPLEDGE Workgroup, talks with Dermatology Times® about the recent iPLEDGE website struggles and guidance on how dermatologists should handle the situation.

Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, sits down with Dermatology Times® to discuss what changes were made to the iPLEDGE platform, examples of how the roll out has been unsuccessful, and how patients should be wary of trying to take old medications.

In this video interview, Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, explains what happened with the iPLEDGE website.

In this week’s Pointers with Dr Portela, the 208SkinDoc explains the differences between lasers that can be used for various treatment goals.

Physicians and their teams have been unable to access the iPLEDGE site during an update to incorporate an FDA-approved modification to the iPLEDGE REMS that took effect December 13, 2021.

In this month's Legal Eagle column, David J. Goldberg, MD, JD, discusses why sexual assault complaints must be made public, even if the defendant is found not guilty.

Arcutis Biotherapeutics has announced data suggesting that the vehicle in the investigational roflumilast cream had similar moisturizing properties as a commercially marketed, dermatologist-recommended, ceramide-containing moisturizer in adults with mild eczema.

This week's edition of the Mainstream Patients features stories about how to identify acne types, how to protect skin during the winter, and more.

Click to see a preview of what to expect this week.

ICYMI, some of this week’s featured content includes an exclusive interview about the unmet needs of vitiligo patients, and articles on international impetigo guidelines, the newly released tapinarof data, and more.

A new study in the Journal of General Internal Medicine finds compliance remains lacking a year after federal price transparency rules went into effect.

Telehealth visits increased, but overall utilization of Part B declined

A new study on the gender pay gap in medicine examined earnings data from more than 80,000 doctors.